A significant association between ARID1A loss and MMRd was noted, present in 22% of all ENOC, highlighting that ARID1A loss is probably confounded by MMRd, given MMRd results in a high mutational burden in an otherwise genomically quiet tumour type. The gene discussed is ARID1A; the disease is neoplasm.